Dietary polyphenols, deacetylases and chromatin remodeling in inflammation

Journal of Nutrigenetics and Nutrigenomics

Volumn 3, Issue 4-6, 2010, Pages 220-230

  Rahman, Irfan ^a   Chung, Sangwoon ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CATECHIN; CURCUMIN; DIALLYL DISULFIDE; GLUCOCORTICOID; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; RESVERATROL; SIRTUIN; SIRTUIN 1; SULFORAPHANE; TRICHOSTATIN A;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; ENZYME INHIBITION; EPIGENETICS; HUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

CHROMATIN ASSEMBLY AND DISASSEMBLY; DIET; FLAVONOIDS; HISTONE DEACETYLASES; HUMANS; INFLAMMATION; PHENOLS;

EID: 79953871147     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000324358     Document Type: Article

References (49)

1. Aggarwal BB, Shishodia S: Suppression of the nuclear factor-kappaB activation pathway by spicederived phytochemicals: reasoning for seasoning. Ann NY Acad Sci 2004;1030:434-441. (Pubitemid 40378943)
2. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I: Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin- 8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 2005;7:32-41. (Pubitemid 40187923)
3. Rahman I, Biswas SK, Kirkham PA: Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 2006;72:1439-1452. (Pubitemid 44666744)
4. Sovak M: Grape extract, resveratrol, and its analogs: a review. J Med Food 2001;4:93-105. (Pubitemid 32738509)
5. Birrell MA, McCluskie K, Wong S, et al: Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J 2005;19:840-841. (Pubitemid 40617402)
6. Donnelly LE, Newton R, Kennedy GE, et al: Antiinflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 2004;287:L774-L783. (Pubitemid 39249390)
7. Manna SK, Mukhopadhyay A, Aggarwal BB: Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000;164:6509-6519. (Pubitemid 30408836)
8. Leiro J, Arranz JA, Fraiz N, et al: Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling. Int Immunopharmacol 2005;5:393-406. (Pubitemid 40126362)
9. Biesalski HK: Polyphenols and inflammation: basic interactions. Curr Opin Clin Nutr Metab Care 2007; 10:724-728. (Pubitemid 350293773)
10. Yang YT, Weng CT, Ho CT, Yen GC: Resveratrol analog-3,5,4'-trimethoxy- trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Mol Nutr Food Res 2009;53:407-416.
11. Venkatesan B, Ghosh-Choudhury N, Das F, et al: Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B. FASEB J 2008;22:3469-3482.
12. Aggarwal BB, Kumar A, Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363-398. (Pubitemid 36361976)
13. Shishodia S, Potdar P, Gairola CG, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2 MMP-9 and cyclin D1. Carcinogenesis 2003;24:1269-1279. (Pubitemid 36927068)
14. Duvoix A, Blasius R, Delhalle S, et al: Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005;223:181-190. (Pubitemid 40719616)
15. Beecher GR: Overview of dietary flavonoids: nomenclature occurrence and intake. J Nutr 2003; 133:3248S-3254S. (Pubitemid 37222252)
16. Syed DN, Afaq F, Kweon MH, et al: Green tea polyphenol EGCG suppresses cigarette smoke condensate- induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene 2007; 26:673-682. (Pubitemid 46204247)
17. Choi KC, Jung MG, Lee YH, et al: Epigallocatechin- 3-gallate a histone acetyltransferase inhibitor inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 2009;69:583-592.
18. Dong Z, Ma W, Huang C, Yang CS: Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res 1997;57:4414-4419. (Pubitemid 27413453)
19. Nomura M, Ma W, Chen N, Bode AM, Dong Z: Inhibition of 12-O-tetradecanoylphorbol-13- acetate-induced NF-kappaB activation by tea polyphenols (-)-epigallocatechin gallate and theaflavins. Carcinogenesis 2000;21:1885-1890.
20. Yang SR, Chida AS, Bauter MR, et al: Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006; 291:L46-L57.
21. Meja KK, Rajendrasozhan S, Adenuga D, et al: Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol 2008;39:312-323.
22. Ito K, Ito M, Elliott WM, et al: Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005;352:1967-1976. (Pubitemid 40638367)
23. Adenuga D, Yao H, March TH, Seagrave J, Rahman I: Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 2009;40:464-473.
24. Barnes PJ, Adcock IM, Ito K: Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005;25:552-563. (Pubitemid 40331188)
25. Imai S, Armstrong CM, Kaeberlein M, Guarente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000;403:795-800. (Pubitemid 30111843)
26. Bordone L, Guarente L: Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 2005;6:298-305. (Pubitemid 40516896)
27. Barnes PJ, Adcock IM: Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373:1905-1917.
28. Ito K, Yamamura S, Essilfie-Quaye S, et al: Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression J Exp Med 2006;203:7-13. (Pubitemid 43139638)
29. Cosio BG, Tsaprouni L, Ito K, et al: Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004; 200:689-695. (Pubitemid 39258317)
30. Cosio BG, Iglesias A, Rios A, et al: Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax 2009;64:424-429.
31. Yang T, Sauve AA: NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. AAPS J 2006;8:E632-E643. (Pubitemid 44644162)
32. Kobayashi Y, Furukawa-Hibi Y, Chen C, et al: SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int J Mol Med 2005;16:237-243.
33. Vaquero A, Scher M, Lee D, et al: Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 2004;16:93-105. (Pubitemid 39330155)
34. Fraga MF, Ballestar E, Villar-Garea A, et al: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005;37:391-400.
35. Pruitt K, Zinn RL, Ohm JE, et al: Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet 2006;2:e40
36. Howitz KT, Bitterman KJ, Cohen HY, et al: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425:191-196. (Pubitemid 37150899)
37. Cohen HY, Miller C, Bitterman KJ, et al: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004;305: 390-392. (Pubitemid 38938153)
38. Daitoku H, Hatta M, Matsuzaki H, et al: Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 2004;101:10042-10047. (Pubitemid 38891191)
39. Brunet A, Sweeney LB, Sturgill JF, et al: Stressdependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011-2015. (Pubitemid 38393275)
40. Yeung F, Hoberg JE, Ramsey CS, et al: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J 2004;23: 2369-2380. (Pubitemid 38954844)
41. Nakamaru Y, Vuppusetty C, Wada H, et al: A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J 2009;23:2810-2819.
42. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I: SIRT1 an antiinflammatory and antiaging protein is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:861-870. (Pubitemid 351600664)
43. Yang SR, Wright J, Bauter M, et al: Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007;292:L567-L576.
44. Myzak MC, Dashwood RH: Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate diallyl disulfide and sulforaphane. Curr Drug Targets 2006;7:443-452. (Pubitemid 43744834)
45. Dashwood RH, Myzak MC, Ho E: Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 2006;27:344-349. (Pubitemid 43159888)
46. Druesne N, Pagniez A, Mayeur C, et al: Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines Carcinogenesis 2004;25:1227-1236. (Pubitemid 38968051)
47. Guyonnet D, Bergès R, Siess MH, et al: Postinitiation modulating effects of allyl sulfides in rat hepatocarcinogenesis. Food Chem Toxicol 2004;42: 1479-1485. (Pubitemid 38844864)
48. Myzak MC, Karplus PA, Chung FL, Dashwood RH: A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 2004;64:5767-5774. (Pubitemid 39095576)
49. Kang J, Chen J, Shi Y, Jia J, Zhang Y: Curcumininduced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 2005;69: 1205-1213. (Pubitemid 40417492)